Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Punit Dhillon
Recent news which mentions Punit Dhillon
Skye Secures $17M And Acquires Novel Phase 2-Ready Cannabinoid 1 Receptor Inhibitor
August 21, 2023
Tickers
SKYE
Tags
Tentarix Biotherapeutics
Benzinga
Paul Grayson
From
Benzinga
Ethics Committee Approves Starting Multiple Ascending Dose Arm Of Phase 1 Study Of Cannabinoid Based Drug For Treatment Of Glaucoma
March 15, 2023
Tickers
SKYE
Tags
Markets
Cannabis
Market News
From
Benzinga
Skye Initiates First-in-Human Phase 1 Clinical Trial For Cannabinoid Based Drug For Treatment Of Glaucoma
November 16, 2022
Tickers
SKYE
Tags
Punit Dhillon
Markets
Cannabis
From
Benzinga
Skye One Step Closer To Initiating Clinical Study Of Its Cannabinoid Based Drug For Treatment Of Glaucoma
September 20, 2022
Tickers
SKYE
Tags
Penny Stocks
Benzinga
SKYE
From
Benzinga
Skye Bioscience Selects NextPharma As Phase 2 Contract Drug Manufacturer
July 21, 2022
Tickers
SKYE
Tags
News
SKYE
Benzinga
From
Benzinga
Skye Bioscience Shares Up On Keeping Novotech As CRO For Phase 1 Trial Of THC Prodrug Candidate For Glaucoma
March 03, 2022
Tickers
SKYE
Tags
Benzinga
Penny Stocks
News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.